315 related articles for article (PubMed ID: 11322269)
1. The role of didanosine in the management of HIV-1 infection.
Gazzard BG; Moyle GJ
Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
[TBL] [Abstract][Full Text] [Related]
2. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
4. [Antiretroviral treatment. Present and future of the combinations].
Gatell-Artigas JM
Rev Neurol; 1996 Dec; 24(136):1627-31. PubMed ID: 9064189
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine plus didanosine in primary HIV-1 infection.
Perrin L; Yerly S; Charvier A; Figueras G; Schockmel GA; Hirschel B
Antivir Ther; 1997 Jan; 2(1):5-11. PubMed ID: 11322267
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on antiretroviral therapy.
Fletcher CV
Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
[TBL] [Abstract][Full Text] [Related]
7. Management of antiretroviral drug therapy in human immunodeficiency virus infection.
Stretcher B
Crit Rev Clin Lab Sci; 1994; 31(2):169-96. PubMed ID: 7917008
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.
Foli A; Lori F; Maserati R; Tinelli C; Minoli L; Lisziewicz J
Antivir Ther; 1997 Jan; 2(1):31-8. PubMed ID: 11322264
[TBL] [Abstract][Full Text] [Related]
9. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
11. Use of hydroxyurea in heavily pretreated patients with HIV infection.
Hermans P; De Wit S; Sommereijns B; O'Doherty E; Clumeck N
Antivir Ther; 1999; 4 Suppl 3():19-22. PubMed ID: 16021867
[TBL] [Abstract][Full Text] [Related]
12. The role of stavudine in the management of adults with HIV infection.
Moyle GJ; Gazzard BG
Antivir Ther; 1997 Dec; 2(4):207-18. PubMed ID: 11327440
[TBL] [Abstract][Full Text] [Related]
13. Didanosine: an updated review of its use in HIV infection.
Perry CM; Noble S
Drugs; 1999 Dec; 58(6):1099-135. PubMed ID: 10651392
[TBL] [Abstract][Full Text] [Related]
14. A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection.
Liuzzi G; Chirianni A; Bagnarelli P; Clementi M; Piazza M
Antivir Ther; 1999; 4(2):95-9. PubMed ID: 10682154
[TBL] [Abstract][Full Text] [Related]
15. Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.
Molina JM; Marcelin AG; Pavie J; Heripret L; De Boever CM; Troccaz M; Leleu G; Calvez V;
J Infect Dis; 2005 Mar; 191(6):840-7. PubMed ID: 15717257
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside combinations for antiretroviral therapy: efficacy of stavudine in combination with either didanosine or lamivudine.
Fisher M
AIDS; 1998; 12 Suppl 3():S9-16. PubMed ID: 15168718
[TBL] [Abstract][Full Text] [Related]
17. Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.
Hanna GJ; Johnson VA; Kuritzkes DR; Richman DD; Brown AJ; Savara AV; Hazelwood JD; D'Aquila RT
J Infect Dis; 2000 Mar; 181(3):904-11. PubMed ID: 10720511
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea: overview of clinical data and antiretroviral and immunomodulatory effects.
Lori F; Lisziewicz J
Antivir Ther; 1999; 4 Suppl 3():101-8. PubMed ID: 16021881
[TBL] [Abstract][Full Text] [Related]
19. [Effect of treatment with nucleoside analogues in subjects with primary genotypic resistance to zidovudine].
Leal M; Caruz A; Rey C; Lissen E
Med Clin (Barc); 1996 Nov; 107(19):755. PubMed ID: 9082095
[No Abstract] [Full Text] [Related]
20. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
Delfraissy JF; Flandre P; Delaugerre C; Ghosn J; Horban A; Girard PM; Norton M; Rouzioux C; Taburet AM; Cohen-Codar I; Van PN; Chauvin JP
AIDS; 2008 Jan; 22(3):385-93. PubMed ID: 18195565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
